Rahul Chaudhary

2 months ago | the-ken.com | Rohin Dharmakumar |Anand Kalyanaraman |Suprita Anupam |Rahul Chaudhary

Subscribe to The Ken’s premium plan and download our beautiful apps for iOS, ipad or android to tune in. Or sign up to Two by Two with a monthly subscription for early access to full episodes on Apple Podcasts.  App Store  Play Store  Apple Podcasts On January 20th, the online publication The Head and Tale broke the news that two of India’s largest payment aggregators and gateways, Razorpay and Cashfree, were severing ties with India’s largest payment orchestrator or router, Juspay.

2 months ago | the-ken.com | Rahul Chaudhary |Seema Singh |Anand Kalyanaraman |Shristi Achar

Move beyond cliched presents this holiday season. Instead, gift something that fuels intellect and inspires change. Share the joy of knowledge with your dear ones. Gift Now Dang, you’re out of gift subscriptions We currently limit the number of free gift subscriptions per subscriber. You’ll get more when you renew your subscription. In the meantime, if you want to tell someone about The Ken, gift them a story. Not now, thanks.

Oct 30, 2024 | medrxiv.org | Neil Kelly |Rahul Chaudhary |Wadih El Khoury |Nishita Kalepalli

S.Y.C. has served as a consultant for Merck, Janssen, and United Therapeutics; S.Y.C. is a director, officer, and shareholder in Synhale Therapeutics; S.Y.C. holds research grants from United Therapeutics, Bayer, and WoodNext Foundation. S.Y.C. has filed patent applications regarding the targeting of metabolism in pulmonary hypertension. Other authors: none.